It will be very informative to further examine the GSK3β-regulated miRnome in human cells to see if the miR subset identified is enriched for particular cellular functions or processes, as this could have important implications for GSK3β as a drug target in cancer, where it displays contrasting and ambiguous roles. This evidence concerns the gene GSK3B and cancer.